Opportunity Information: Apply for PAR 18 904
Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 Clinical Trial Not Allowed) is an NIH discretionary grant opportunity (Funding Opportunity Number PAR 18 904; CFDA 93.242) designed to fund research that uses existing electronic medical records (EMRs) and other large-scale, real-world data resources to accelerate psychiatric genetic research. The central idea is to take advantage of already-established, population-based cohorts, registries, and health system datasets and pair them with individual-level genetic information to study the causes of severe mental disorders in a way that is efficient, scalable, and grounded in routine clinical data.
The FOA emphasizes molecular epidemiologic approaches that are both creative and practical. Applicants are expected to integrate genetic data in multiple forms, including polygenic risk (the combined effect of many common genetic variants across the genome) as well as specific risk variants, loci, and biological networks that have been implicated in psychiatric conditions. Rather than focusing on small, narrowly defined samples, the program is aimed at leveraging large datasets that can support robust analyses of complex disorders. This often means working with health systems that have broad patient coverage, diverse populations, longitudinal clinical histories, and linkable data sources.
A key scientific objective is to clarify how genetic liability interacts with environmental and clinical factors across the life course. The FOA frames severe mental disorders as conditions with complex etiology, meaning they arise from many contributing influences rather than a single cause. Projects supported under this announcement are expected to move beyond simple genetic association and toward models that examine interplay: how polygenic risk and specific genetic factors combine with environmental exposures, social determinants, treatment histories, comorbidities, and other real-world influences captured in EMRs. The long-term goal is to translate that improved etiologic understanding into better diagnostic strategies and, ultimately, improved treatment and outcomes for individuals with mental disorders.
Because this is an R01 mechanism, the program is intended for substantial, hypothesis-driven research projects that can produce meaningful advances, not pilot-only efforts. At the same time, the FOA strongly encourages efficiency by reusing existing infrastructure and data resources wherever possible, such as established registries, biobanks connected to health systems, and cohorts where genetic data already exist or can be feasibly integrated. The focus on EMR-linked research implies attention to phenotyping from clinical records, longitudinal follow-up, and potentially large-scale analyses that would be difficult to execute through traditional recruitment alone.
This opportunity explicitly does not allow clinical trials, which means proposed studies should not be designed to prospectively assign interventions to participants in order to evaluate health-related outcomes. The work should instead be observational and analytic in nature, using available clinical and genetic data to understand risk, trajectories, and mechanisms, including gene-environment interaction and related modeling. Projects can still involve human subjects research and secondary use of clinical data, but they must fit within the non-trial framework.
Eligibility is broad and includes many types of organizations that can support biomedical research. Eligible applicants include state, county, and local governments; special districts; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and Native American tribal governments (federally recognized) and tribal organizations (including those other than federally recognized tribal governments). The FOA also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, faith-based or community-based organizations, Hispanic-serving institutions, HBCUs, tribally controlled colleges and universities (TCCUs), U.S. territories or possessions, regional organizations, eligible federal agencies, and non-U.S. (foreign) entities.
Administrative details in the source information indicate the opportunity was created on 2018-08-16 and lists an original closing date of 2021-09-07. The award ceiling and expected number of awards are not specified in the provided data, which typically means applicants would need to consult the full FOA text and NIH institute-specific guidance for budget expectations and funding levels. Overall, the program is aimed at advancing psychiatric genetics by bringing together EMR-scale clinical data and modern genetic risk modeling, with a particular emphasis on understanding how inherited risk and environmental context jointly shape severe mental illness in real populations.Apply for PAR 18 904
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2018-08-16.
- Applicants must submit their applications by 2021-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)
Previous opportunity: CESU White Nose Syndrome Funding Proposal
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 904
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 904) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: RCMI Research Coordination Network (RRCN) (U54 Clinical Trial Not Allowed) Apply for RFA MD 18 011 Funding Number: RFA MD 18 011 Agency: National Institutes of Health Category: Health Funding Amount: $1,300,000 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Apply for PA 18 906 Funding Number: PA 18 906 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Integration and Resource Center (DIRC) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional) Apply for RFA RM 18 031 Funding Number: RFA RM 18 031 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Omics Data Generation Centers (ODGCs) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional) Apply for RFA RM 18 032 Funding Number: RFA RM 18 032 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain (UM1 Clinical Trial Optional) Apply for RFA RM 18 034 Funding Number: RFA RM 18 034 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Coordination Center for Common Fund Acute to Chronic Pain Signatures (A2CPS) Program (U24 Clinical Trial Optional) Apply for RFA RM 18 035 Funding Number: RFA RM 18 035 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Pain from Musculoskeletal Trauma (UM1 Clinical Trial Optional) Apply for RFA RM 18 033 Funding Number: RFA RM 18 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sustainable Peri-urban Water and Sanitation services Apply for BAA DRC WASH 2018 Funding Number: BAA DRC WASH 2018 Agency: Democratic Republic of the Congo USAID-Kinshasa Category: Health Funding Amount: Case Dependent |
| New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 Clinical Trial Not Allowed) Apply for PA 18 908 Funding Number: PA 18 908 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed) Apply for PA 18 907 Funding Number: PA 18 907 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trials Not Allowed) Apply for PAR 18 909 Funding Number: PAR 18 909 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01) (Clinical Trial Required) Apply for PAR 18 910 Funding Number: PAR 18 910 Agency: National Institutes of Health Category: Health Funding Amount: $3,000,000 |
| U.S. - India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed) Apply for PAR 18 912 Funding Number: PAR 18 912 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp)- Clinical Trial Not Allowed Apply for PA 18 914 Funding Number: PA 18 914 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Screening and Management of Unhealthy Alcohol Use in Primary Care: Dissemination and Implementation of PCOR Evidence (R18) Apply for RFA HS 18 002 Funding Number: RFA HS 18 002 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R01 Clinical Trial Optional) Apply for RFA MH 19 510 Funding Number: RFA MH 19 510 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed) Apply for PAR 18 923 Funding Number: PAR 18 923 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R21 Clinical Trial Optional) Apply for RFA MH 19 511 Funding Number: RFA MH 19 511 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp) Apply for PA 18 926 Funding Number: PA 18 926 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovative Technologies for HIV Behavioral and Social Science Research (R43/R44 Clinical Trial Optional) Apply for PA 18 928 Funding Number: PA 18 928 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 904", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
